Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

AnaptysBio completes generation of therapeutic antibodies for partner

Sep. 2, 2011

Synageva and Mitsubishi Tanabe Pharma sign research and development partnership

Sep. 2, 2011

Chugai in-licenses Japanese rights to two monoclonal antibodies

Sep. 2, 2011

STADA and Gedeon Richter sign agreement for rituximab and trastuzumab biosimilars

Sep. 2, 2011

Kissei obtains Japanese rights to DNA topoisomerase 2 inhibitor for anthracycline extravasation

Sep. 1, 2011

Anacor and MMV extend development agreement for malaria drug

Sep. 1, 2011

KemPharm and MonoSol Rx to codevelop KP-415 for ADHD

Sep. 1, 2011

Zymeworks and Merck & Co. to collaborate

Aug. 31, 2011

Adimab announces new collaborations

Aug. 30, 2011

Ipsen and Inspiration Biopharmaceuticals sign European partnership agreement in hemophilia

Aug. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...